<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">DVD</journal-id>
<journal-id journal-id-type="hwp">spdvd</journal-id>
<journal-title>British Journal of Diabetes &amp; Vascular Disease</journal-title>
<issn pub-type="ppub">1474-6514</issn>
<issn pub-type="epub">XXXX-XXXX</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1474651412473343</article-id>
<article-id pub-id-type="publisher-id">10.1177_1474651412473343</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Low carbohydrate meals or a small dose of insulin normalises one-hour blood glucose in a woman with normal glucose tolerance and elevated one-hour postload glucose: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Vindedzis</surname><given-names>Sally A</given-names></name>
<xref ref-type="aff" rid="aff1-1474651412473343">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Marsh</surname><given-names>Beryl</given-names></name>
<xref ref-type="aff" rid="aff1-1474651412473343">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sherriff</surname><given-names>Jill L</given-names></name>
<xref ref-type="aff" rid="aff2-1474651412473343">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dhaliwal</surname><given-names>Satvinder S</given-names></name>
<xref ref-type="aff" rid="aff2-1474651412473343">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Stanton</surname><given-names>Kim G</given-names></name>
<xref ref-type="aff" rid="aff1-1474651412473343">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1474651412473343"><label>1</label>Department of Endocrinology and Diabetes, Royal Perth Hospital, Perth, WA, Australia</aff>
<aff id="aff2-1474651412473343"><label>2</label>School of Public Health, Curtin Health Innovation Research Institute, Curtin University, Bentley, WA, Australia</aff>
<author-notes>
<corresp id="corresp1-1474651412473343">Sally Vindedzis, Department of Endocrinology and Diabetes, Royal Perth Hospital, GPO Box X2213, Perth, Western Australia, 6001, Australia. Email: <email>sally.vindedzis@postgrad.curtin.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>13</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>105</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March/April 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1474651412473343">
<title>Abbreviations:</title>
<p>BGL  blood glucose level</p>
<p>BMI  body mass index</p>
<p>HbA<sub>1C</sub>  glycated haemoglobin A<sub>1C</sub></p>
<p>IFG  impaired fasting glucose</p>
<p>IGT  impaired glucose tolerance</p>
<p>NGT  normal glucose tolerance</p>
<p>OGTT  oral glucose tolerance test</p>
<p>SBGM  self blood glucose monitoring</p>
</sec>
<sec id="section2-1474651412473343" sec-type="intro">
<title>Introduction</title>
<p>Diabetes is diagnosed by 2-hour BGL ≥ 11.1 mmol/L on OGTT, fasting BGL ≥ 7.0 mmol/L or HbA<sub>1C</sub> ≥ 6.5%.<sup><xref ref-type="bibr" rid="bibr1-1474651412473343">1</xref></sup> IFG and IGT are similarly diagnosed by elevated fasting and 2-hour BGLs.<sup><xref ref-type="bibr" rid="bibr1-1474651412473343">1</xref></sup> Although 1-hour BGL is routinely measured, results are classified as NGT if fasting and 2-hour levels are normal, irrespective of elevation at 1 hour. It has, however, been shown that 1-hour postload BGL is a strong predictor of future risk for type 2 diabetes and vascular disease, even in those with NGT.<sup><xref ref-type="bibr" rid="bibr2-1474651412473343">2</xref>,<xref ref-type="bibr" rid="bibr3-1474651412473343">3</xref></sup> Additionally Meisinger <italic>et al</italic>. identified 1-hour postload glycaemia as a long-term predictor for all-cause mortality in men without diabetes.<sup><xref ref-type="bibr" rid="bibr4-1474651412473343">4</xref></sup> There is no normal range for 1-hour glucose, but ≥ 8.6 mmol/L has been identified as a cut-off marking increased cardiovascular and diabetes risk.<sup><xref ref-type="bibr" rid="bibr2-1474651412473343">2</xref>,<xref ref-type="bibr" rid="bibr3-1474651412473343">3</xref>,<xref ref-type="bibr" rid="bibr5-1474651412473343">5</xref></sup> It has been suggested that recognition and management of those with NGT and 1-hour glucose ≥ 8.6mmol/L may reduce incidence of diabetes and vascular events.<sup><xref ref-type="bibr" rid="bibr3-1474651412473343">3</xref>,<xref ref-type="bibr" rid="bibr4-1474651412473343">4</xref></sup></p>
<p>This case report has been approved by Curtin University Human Research Ethics Committee, an institutional ethics committee, and a consent form has been signed.</p>
</sec>
<sec id="section3-1474651412473343" sec-type="cases">
<title>Case report</title>
<p>A.J., a 59-year-old Caucasian woman, had noted elevated BGLs soon after eating for about 10 years. In 2005 her OGTT showed a 1-hour level of 8.0 mmol/L with normal fasting and 2-hour levels (4.5 and 4.7 mmol/L respectively). When repeated in 2008 her BGL reached 11.7 mmol/L at 1 hour and was down to 7.2 mmol/L by 2 hours. Concurrent assessment of serum insulin showed a 1-hour level of 73 mU/L, remaining elevated at 2 hours (27 mU/L). SBGM had shown normal fasting levels on most occasions, but had risen to 6–8 mmol/L with acute illness. One-hour postprandial levels were often above 10 mmol/L when she ate a carbohydrate-containing meal. Apart from postprandial hyperglycaemia A.J. had no other vascular risk factors and did not fit criteria for metabolic syndrome. She had a raised LDL which responded to Lipitor but no evidence of a metabolic dyslipidaemia. Her blood pressure was 100/70. Until 2008 A.J. had noted increased postprandial hunger resulting in slow weight gain, although her BMI remained well within the normal range (2001, 60 kg, 20.5; 2008, 64.3 kg, 22.3).</p>
<p>Repeat SBGM over four standard meals showed a 1-hour postload rise significantly associated with meal carbohydrate quantity (p=0.024) but not glycaemic index (p=0.51) (<xref ref-type="table" rid="table1-1474651412473343">Table 1</xref>). Mean 2-hour postload drop was 5.6±2.6 mmol/L.</p>
<table-wrap id="table1-1474651412473343" position="float">
<label>Table 1.</label>
<caption>
<p>Standard meals: content, carbohydrate load, glycaemic index and mean 1-hour postload rise in blood glucose.</p>
</caption>
<graphic alternate-form-of="table1-1474651412473343" xlink:href="10.1177_1474651412473343-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Stndard meal</th>
<th align="left">Foods</th>
<th align="left">CHO (g)</th>
<th align="left">GI</th>
<th align="left">1-h BGL mmol/L</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Meal 1</bold></td>
<td>1½ slice mixed grain toast</td>
<td>41.8</td>
<td>47.8</td>
<td>8.2±1.8</td>
</tr>
<tr>
<td/>
<td>1 dsp dairy soft</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>1 dsp apricot jam</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>70 mL orange juice</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>Coffee + 50 mL soy milk</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>Meal 2</bold></td>
<td>Long wheat roll</td>
<td>28.2</td>
<td>59</td>
<td>7.7±0.9</td>
</tr>
<tr>
<td/>
<td>Mixed green salad</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>45 g cheese</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>Meal 3</bold></td>
<td>Cannellini vegetable casserole</td>
<td>34.9</td>
<td>48.3</td>
<td>6.8±2.9</td>
</tr>
<tr>
<td/>
<td>2 tbsp basmati rice</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>Green salad</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>Naan bread – palm sized</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>80 mL dry wine</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td><bold>Meal 4</bold></td>
<td>1 mixed grain toast</td>
<td>25.1</td>
<td>46.1</td>
<td>3.9±0.9</td>
</tr>
<tr>
<td/>
<td>1 dsp dairy soft</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>2 tsp vegemite</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>80 mL orange juice</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td>¼ apple</td>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1474651412473343"><p><bold>Key:</bold> CHO: carbohydrate; dsp: dessert spoon; GI: glycaemic index; 1-h BGL: mean rise blood glucose</p></fn>
<fn id="table-fn2-1474651412473343"><p>1-hour postload.</p></fn>
<fn id="table-fn3-1474651412473343"><p>Carbohydrate content from Foodworks 7, Xyris Software (Aust) Pty Ltd 2012, Qld, Australia.</p></fn>
<fn id="table-fn4-1474651412473343"><p>GI from Atkinson FS <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr6-1474651412473343">6</xref></sup></p></fn>
</table-wrap-foot>
</table-wrap>
<p>A.J. commenced sitagliptin but after 4 months of treatment felt there was insufficient change in her 1-hour levels to warrant continuing. She elected to limit carbohydrate intake in most meals (5-10 g/meal) and use a small dose of short-acting insulin (½−1½units) before those meals when she elected to have more carbohydrate. Mean repeat SBGM results are shown in <xref ref-type="fig" rid="fig1-1474651412473343">Figure 1</xref>. Repeated measures ANOVA showed a significant difference between 1-hour postload rise for low carbohydrate and insulin-treated meals compared with no treatment or sitagliptin (p&lt;0.001); there was no significant difference between no treatment and sitagliptin (p=0.26). On her current regime postprandial hunger has diminished with 3.6 kg weight loss over 4 years.</p>
<fig id="fig1-1474651412473343" position="float">
<label>Figure 1.</label>
<caption>
<p>Mean rise in 1-hour postload blood glucose level (BGL) following four standard meals.</p>
</caption>
<graphic xlink:href="10.1177_1474651412473343-fig1.tif"/></fig>
</sec>
<sec id="section4-1474651412473343" sec-type="discussion">
<title>Discussion</title>
<p>The significance of elevated postload 1-hour BGL is currently being debated. Whereas a diagnosis of IFG/IGT elicits advice on diabetes risk, diet, exercise and, more recently, metformin,<sup><xref ref-type="bibr" rid="bibr7-1474651412473343">7</xref></sup> NGT with 1-hour BGL ≥ 8.6 mmol/L is classified normal and no preventative measures taken, despite evidence that these individuals have an atherogenic profile similar to those with IGT<sup><xref ref-type="bibr" rid="bibr5-1474651412473343">5</xref></sup> and a similarly increased risk of type 2 diabetes.<sup><xref ref-type="bibr" rid="bibr2-1474651412473343">2</xref></sup></p>
<p>We have described a case where two relatively straightforward interventions resulted in normalisation of elevated 1-hour postload BGL. Surprisingly sitagliptin, which has demonstrated positive effects on first phase insulin secretion,<sup><xref ref-type="bibr" rid="bibr8-1474651412473343">8</xref></sup> had relatively little effect, although there was a trend to decreased 1-hour BGL with increased carbohydrate load. Our subject therefore chose a combination of mainly low carbohydrate meals combined with a small insulin dose before meals with &gt; 10 g carbohydrate. One possible pitfall of low carbohydrate diets is increased saturated fat intake, but with proper design, this can be avoided. Such diets generally have good satiety and acceptance, although there is some evidence that adherence decreases over time.<sup><xref ref-type="bibr" rid="bibr9-1474651412473343">9</xref></sup> Insulin treatment is more intrusive. A small dose before carbohydrate-containing meals only, minimises the risk of hypoglycaemic episodes, but still entails the necessity of SBGM. Our subject additionally noted that treatment appeared to reduce her postprandial hunger, thus facilitating weight loss. Her insulin profile at OGTT was consistent with Harada’s thesis of decreased early phase insulin secretion giving rapid postprandial rise in BGL thus exaggerated second phase insulin response resulting in a rapid fall in BGL to normal levels by 90 minutes.<sup><xref ref-type="bibr" rid="bibr10-1474651412473343">10</xref></sup> Her resulting postload drop at 2 hours is consistent with relative hypoglycaemia<sup><xref ref-type="bibr" rid="bibr11-1474651412473343">11</xref></sup> and could well result in hunger and putative weight gain.</p>
<p>Cubeddu <italic>et al</italic>. showed that 8.3% of those with NGT have1-hour BGL ≥ 8.6 mmol/L,<sup><xref ref-type="bibr" rid="bibr3-1474651412473343">3</xref></sup> so this condition is not unusual, but treatment of it is. This case demonstrates a practical intervention effective over 4 years. A case series is now needed to further investigate this.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn>
<fn fn-type="conflict">
<label>Declaration of conflicting interests</label>
<p>The authors have no conflicts of interest to declare</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1474651412473343">
<label>1.</label>
<citation citation-type="journal"><collab>American Diabetes Association</collab>. <article-title>Diagnosis and classification of diabetes mellitus</article-title>. <source>Diabetes Care</source> <year>2012</year>; <volume>35</volume>(<supplement>supplement 1</supplement>): <fpage>S64</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr2-1474651412473343">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abdul-Ghani</surname><given-names>MA</given-names></name>
<name><surname>Abdul-Ghani</surname><given-names>T</given-names></name>
<name><surname>Ali</surname><given-names>N</given-names></name>
<name><surname>DeFronzo</surname><given-names>RA</given-names></name>
</person-group>. <article-title>One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes</article-title>. <source>Diabetes Care</source> <year>2008</year>; <volume>31</volume>: <fpage>1650</fpage>-<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr3-1474651412473343">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cubeddu</surname><given-names>LX</given-names></name>
<name><surname>Hoffmann</surname><given-names>IS</given-names></name>
</person-group>. <article-title>One-hour postload plasma glucose levels, a predictor of additional risk for diabetes: prevalence, mechanisms, and associated cardiovascular and metabolic risk factors in Hispanics</article-title>. <source>Metab Syndr Relat Disord</source> <year>2010</year>; <volume>8</volume>: <fpage>395</fpage>-<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr4-1474651412473343">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meisinger</surname><given-names>C</given-names></name>
<name><surname>Wölke</surname><given-names>G</given-names></name>
<name><surname>Brasche</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Postload plasma glucose and 30-year mortality among nondiabetic middle-aged men from the general population: The ERFORT Study</article-title>. <source>Ann Epidemiol</source> <year>2006</year>; <volume>16</volume>: <fpage>534</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr5-1474651412473343">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Succurro</surname><given-names>E</given-names></name>
<name><surname>Marini</surname><given-names>MA</given-names></name>
<name><surname>Arturi</surname><given-names>F</given-names></name>
<etal/></person-group>. <article-title>Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis</article-title>. <source>Atherosclerosis</source> <year>2009</year>; <volume>207</volume>: <fpage>245</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr6-1474651412473343">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Atkinson</surname><given-names>FS</given-names></name>
<name><surname>Foster-Powell</surname><given-names>K</given-names></name>
<name><surname>Brand-Miller</surname><given-names>JC</given-names></name>
</person-group>. <article-title>International Tables of Glycemic Index and Glycemic Load Values: 2008</article-title>. <source>Diabetes Care</source> <year>2008</year>; <volume>31</volume>: <fpage>2281</fpage>-<lpage>3</lpage>.</citation>
</ref>
<ref id="bibr7-1474651412473343">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nathan</surname><given-names>DM</given-names></name>
<name><surname>Davidson</surname><given-names>MB</given-names></name>
<name><surname>DeFronzo</surname><given-names>RA</given-names></name>
<etal/></person-group>. <article-title>Impaired fasting glucose and impaired glucose tolerance</article-title>. <source>Diabetes Care</source> <year>2007</year>; <volume>30</volume> :<fpage>753</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr8-1474651412473343">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aaboe</surname><given-names>K</given-names></name>
<name><surname>Knop</surname><given-names>FK</given-names></name>
<name><surname>Vilsboll</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus</article-title>. <source>Diabetes Obes Metab</source> <year>2010</year>; <volume>12</volume>: <fpage>323</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr9-1474651412473343">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berkow</surname><given-names>S</given-names></name>
<name><surname>Barnard</surname><given-names>N</given-names></name>
<name><surname>Eckart</surname><given-names>J</given-names></name>
<name><surname>Katcher</surname><given-names>H</given-names></name>
</person-group>. <article-title>Four therapeutic diets: adherence and acceptability</article-title>. <source>Can J Diet Pract Res</source> <year>2010</year>; <volume>71</volume>: <fpage>199</fpage>-<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr10-1474651412473343">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harada</surname><given-names>N</given-names></name>
<name><surname>Fukushima</surname><given-names>M</given-names></name>
<name><surname>Toyoda</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Factors responsible for elevation of 1-h postchallenge plasma glucose levels in Japanese men</article-title>. <source>Diabetes Res Clin Pract</source> <year>2008</year>; <volume>81</volume>: <fpage>284</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr11-1474651412473343">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cryer</surname><given-names>PE</given-names></name>
<name><surname>Axelrod</surname><given-names>L</given-names></name>
<name><surname>Grossman</surname><given-names>AB</given-names></name>
<etal/></person-group>. <article-title>Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline</article-title>. <source>J Clin Endocrinol Metab</source> <year>2009</year>; <volume>94</volume>: <fpage>709</fpage>-<lpage>28</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>